TOY

TOBRAMYCIN

TOY is found in 9 entries

TOY as free ligands, exist in 9 entries. Examples include 1LC4, 1M4D, 3SG8

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name TOBRAMYCIN
Identifiers (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
Synonyms 4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY-TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
Formula C18 H37 N5 O9
Molecular Weight 467.51 g/mol
Type non-polymer
Isomeric SMILES NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
InChI InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1
InChI Key NLVFBUXFDBBNBW-PBSUHMDJSA-N

Chemical Details

Formal Charge 0
Atom Count 69
Chiral Atom Count 14
Chiral Atoms C11 C21 C41 C51 C12 C32 C42 C52 C62 C13 C23 C33 C43 C53
Bond Count 71
Aromatic Bond Count 0

Drug Info: DrugBank

DrugBank ID DB00684   (Stereoisomeric match)
Name Tobramycin
Groups
  • approved
  • investigational
Description An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the pseudomonas species. It is a 10% component of the antibiotic complex, nebramycin, produced by the same species. [PubChem]
Synonyms
  • 3'-Deoxykanamycin b
  • Nebramycin 6
  • Nebramycin factir 6
  • Nebramycin-Faktor 6
  • O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
  • Tobracin (tn)
  • Tobramicina
  • Tobramicina
  • Tobramycin
  • Tobramycine
  • Tobramycinum
  • Tobrex (tn)
[more]
Salts Tobramycin Sulfate
Brand Names
  • Aj-tobramycin
  • Apo-tobramycin
  • Bethkis
  • Jamp-tobramycin
  • Kitabis Pak
  • Nebcin Inj 1.2gm/30ml
  • Nebcin Inj 10mg/ml
  • Nebcin Inj 10mg/ml (vantage Vial)
  • Nebcin Inj 40mg/ml
  • Nebcin Inj 60mg
  • Nebcin Inj 80mg
  • PMS-tobramycin 0.3% Ophthalmic Solution
  • Sandoz Tobramycin 0.3%
  • Teva-tobramycin
  • Tobi
  • Tobi Podhaler
  • Tobradex
  • Tobradex Oph Ointment
  • Tobradex Oph Sus
  • Tobradex ST
  • Tobramycin
  • Tobramycin In Sodium Chloride
  • Tobramycin Inhalation Solution
  • Tobramycin Injection
  • Tobramycin Injection USP
  • Tobramycin Injection, USP
  • Tobramycin Ophthalmic Solution USP 0.3%
  • Tobramycin Sulfate
  • Tobramycin and Dexamethasone
  • Tobramycin for Injection
  • Tobramycin for Injection U.S.P.
  • Tobrex
  • Tobrex 0.3% Ophthalmic Sol
  • Tobrex Ophthalmic Ont 3mg/gm
  • Tobrexan
  • Zylet
  • Aktob
  • Alveoterol
  • Amgy
  • Bactob
  • Belbarmicina
  • Bideon Biotic
  • Bioptic
  • Bramitob
  • Gernebcin
  • Nebcin
  • Obracin
  • Tobracin
  • Tobramaxin
[more]
Affected Organism Enteric bacteria and other eubacteria
Indication For the treatment of pseudomonas aeruginosa lung infections. Also being investigated for use in the treatment of sinus infections.
Pharmacology Tobramycin, an aminoglycoside antibiotic obtained from cultures of Streptomyces tenebrarius, is used in combination with other antibiotics to treat urinary tract infections, gynecologic infections, peritonitis, endocarditis, pneumonia, bacteremia and sepsis, respiratory infections including those associated with cystic fibrosis, osteomyelitis, and diabetic foot and other soft-tissue infections. It acts primarily by disrupting protein synthesis, leading to altered cell membrane permeability, progressive disruption of the cell envelope, and eventual cell death. Tobramycin has in vitro activity against a wide range of gram-negative organisms including Pseudomonas aeruginosa.
Mechanism of action Tobramycin binds irreversibly to one of two aminoglycoside binding sites on the 30 S ribosomal subunit, inhibiting bacterial protein synthesis. Tobramycin may also destabilize bacterial memebrane by binding to 16 S 16 S r-RNA. An active transport mechanism for aminoglycoside uptake is necessary in the bacteria in order to attain a significant intracellular concentration of tobramycin.
Route of administration
  • inhalation
  • intramuscular; intravenous
  • intravenous
  • ophthalmic
  • oral
  • oral; respiratory (inhalation)
  • respiratory (inhalation)
[more]
Categories
  • Anti-Bacterial Agents
  • ["D27.505.954.122.085"]
  • Aminoglycosides
  • ["D09.408.051"]
ATC-Code
  • J01GB01
  • S01AA12
AHFS-Code
  • 08:12.02
  • 52:04.04
CAS number 32986-56-4

Drug Targets

Name Sequence Search Pharmacological Action Actions
30S ribosomal protein S12 Search yes inhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682